Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yiqi fumai for injection
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Administration
- Intravenous
01
Overview
Yiqi Fumai for Injection (lyophilized) is a modern Traditional Chinese Medicine (TCM) injection developed by Tasly Pharmaceutical Group. It is derived from the classic TCM formula 'Shengmai San' and is primarily indicated for the treatment of chronic heart failure and coronary heart disease. The formulation consists of extracts from *Panax ginseng* (Ginseng), *Ophiopogon japonicus* (Ophiopogon), and *Schisandra chinensis* (Schisandra). Its mechanism of action involves improving myocardial energy metabolism, protecting against ischemia-reperfusion injury, and exerting anti-inflammatory and anti-apoptotic effects on cardiomyocytes. It is widely used in China for cardiovascular conditions and is administered intravenously.
- Brand names
- Yiqi Fumai
- Other names
- 注射用益气复脉（冻干）YQFMYiqi Fumai Lyophilized Injection
02
Targets
AMPK (Adenosine monophosphate–activated protein kinase)NF-κBCASP3 (Caspase-3)
Beyond the preview
Go deeper on yiqi fumai for injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yiqi fumai for injection.